Skip to main content

Investor

By Laura Lovett | 04:10 pm | February 10, 2021
The M&A is expected to help Flow expand to treat new mental health conditions that are commonly comorbid with depression. 
By Mallory Hackett | 11:00 am | February 10, 2021
Equip, a virtual eating disorder treatment program, has closed a Series A financing round worth $13 million led by Optum Ventures.
By Dave Muoio | 04:22 pm | February 09, 2021
Also: Base launches home wellness testing subscription with $3.4 million raise; Daybreak Health delivers online counseling to teens with $1.8 million seed round.
By Dave Muoio | 12:59 pm | February 09, 2021
Saykara's founder and team will be augmenting Nuance's R&D division.
By Dave Muoio | 03:47 pm | February 08, 2021
Founded in 2012, Oscar has grown to an approximate membership of 529,000, an annual revenue of $1.67 billion and a lifetime accumulated deficit of $1.43 billion.
By Dave Muoio | 04:00 pm | February 04, 2021
Also: FDA pushes back on Nanox's "digital X-ray" 510(k) and clears B-Secur's ECG algorithms.
By Mallory Hackett | 12:56 pm | February 04, 2021
The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.  
By Dave Muoio | 03:59 pm | February 03, 2021
Also: Kaiser Permanente doubles down on the cloud with Accenture and Microsoft; Boehringer Ingelheim arms its reps with BreezoMeter's air quality data.
By Laura Lovett | 03:48 pm | February 03, 2021
The company plans to use the money to grow in the life science and AI research space. 
By Dave Muoio | 03:02 pm | February 03, 2021
The startup formerly known as Heart Health Intelligence is undergoing the FDA clearance process for its Heart Seat device.